Benitec Biopharma (BNTC) reported a net loss attributable to shareholders of $45.5 million, or $0.98 per basic and diluted share, for the fiscal year ended June 30, 2026. The company reported $180.0 million in cash and cash equivalents at year-end.
The company said all six low-dose BB-301 Cohort 1 patients completed 12-month follow-up, while the three-patient high-dose Cohort 2 was fully enrolled and treated. Benitec expects to initiate a BB-301 pivotal trial in mid-2027.
- Total operating expenses were $51.2 million, compared with $41.8 million in fiscal 2025.
- Research and development expenses were $23.4 million; general and administrative expenses were $27.8 million.
- Benitec held an FDA Type C meeting in the third quarter of 2026 regarding BB-301 pivotal-study design, with meeting minutes anticipated in October.
- Interim BB-301 Phase 1b/2a results are scheduled for presentation at the ESGCT Annual Congress in Hamburg, Germany, on October 27-30, 2026.
$BNTC Hedge Fund Activity
We have seen 50 institutional investors add shares of $BNTC stock to their portfolio, and 36 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SIREN, L.L.C. removed 775,000 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $8,253,750
- SIMPLIFY ASSET MANAGEMENT INC. added 443,315 shares (+78.8%) to their portfolio in Q2 2026, for an estimated $5,931,554
- NANTAHALA CAPITAL MANAGEMENT, LLC added 400,000 shares (+38.5%) to their portfolio in Q1 2026, for an estimated $4,260,000
- MILLENNIUM MANAGEMENT LLC added 269,235 shares (+41.3%) to their portfolio in Q2 2026, for an estimated $3,602,364
- BLACKROCK, INC. added 221,397 shares (+18.7%) to their portfolio in Q2 2026, for an estimated $2,962,291
- CITADEL ADVISORS LLC added 154,142 shares (+876.8%) to their portfolio in Q1 2026, for an estimated $1,641,612
- LONGAEVA PARTNERS L.P. removed 110,126 shares (-88.1%) from their portfolio in Q2 2026, for an estimated $1,473,485
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.